Vico Therapeutics
9 known investors
Vico Therapeutics develops targeted genetic medicines for neurological disorders, with a focus on antisense oligonucleotide therapies designed to address the underlying genetic causes of diseases like Huntington's disease and spinocerebellar ataxias.
Founders & leadership
LD
Luc DochezChair and Founder
JM
Investors · 9
Droia Ventures✓ verifiedLeuven · $540K
Kurma Partners✓ verifiedParis · $162K – $10.8M
Pureos Bioventures✓ verifiedPfäffikon
EQT Life Sciences✓ verifiedLuxembourg · $11M – $66M
Seroba Life SciencesDublin · $540K – $7.6M
EurazeoreportedParis
Idinvest Partnersreported
Also in the syndicate · 2
Ackermans & van HaarenleadPolaris Partners
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BJun 2024Source ↗
- Undisclosed amountSeries BJan 2024
Ackermans & van Haaren (lead), Droia Ventures (lead), EQT Life Sciences (lead), Kurma Partners (lead), Eurazeo, Polaris Partners, Pureos Bioventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Vico Therapeutics do?
- Vico Therapeutics develops targeted genetic medicines for neurological disorders, with a focus on antisense oligonucleotide therapies designed to address the underlying genetic causes of diseases like Huntington's disease and spinocerebellar ataxias.
- Who founded Vico Therapeutics?
- Vico Therapeutics was founded by Luc Dochez, Josh Mandel-Brehm.
- Who are Vico Therapeutics's investors?
- Vico Therapeutics's investors include Droia Ventures, Kurma Partners, Pureos Bioventures, EQT Life Sciences, Seroba Life Sciences, Eurazeo, Idinvest Partners.